Home LiteratureArticle Details
PMID: 16694453 Published · ppublish English Journal Article

DEVELOPMENT OF ANTIFIBRINOLYTIC PROPERTIES IN BLOOD OF PATIENTS WITH RHEUMATIC FEVER, CHRONIC INFECTIVE ARTHRITIS AND BACTERIAL ENDOCARDITIS.

The Journal of clinical investigation ·Vol. 16 ·No. 1 ·1937-01-00 ·Pages 145-53

Waaler E

Abstract

暂无摘要

Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Waaler E
University Medical Clinic B. of Rikshospitalet, Oslo, Norway.
References (5)
5 references, click to expand
  1. FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.
    J Clin Invest. 1934 Jan;13(1):47-78 PMID: 16694203
  2. THE OCCURRENCE OF ANTIFIBRINOLYTIC PROPERTIES IN THE BLOOD OF PATIENTS WITH ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.
    J Clin Invest. 1935 Mar;14(2):276-84 PMID: 16694298
  3. STUDIES ON THE IMMUNE RESPONSE OF THE RHEUMATIC SUBJECT AND ITS RELATIONSHIP TO ACTIVITY OF THE RHEUMATIC PROCESS. VI. THE SIGNIFICANCE OF THE RISE OF ANTISTREPTOLYSIN LEVEL IN THE DEVELOPMENT OF RHEUMATIC ACTIVITY.
    J Clin Invest. 1935 Nov;14(6):769-81 PMID: 16694347
  4. THE RESISTANCE TO FIBRINOLYTIC ACTIVITY OF THE HEMOLYTIC STREPTOCOCCUS WITH SPECIAL REFERENCE TO PATIENTS WITH RHEUMATIC FEVER AND RHEUMATOID (ATROPHIC) ARTHRITIS.
    J Clin Invest. 1935 Jan;14(1):119-23 PMID: 16694269
  5. STREPTOCOCCAL AGGLUTININS AND ANTISTREPTOLYSINS IN RHEUMATOID (ATROPHIC) ARTHRITIS.
    J Clin Invest. 1935 Sep;14(5):505-15 PMID: 16694324
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1937-01-00
Pages
145-53
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC424854
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]